Mspt Disability Assessment
Mspt Disability Assessment - Related Videos
11:35
The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
0 Views •
Cited by 106 •
2014
Precise measurement of neurological and neuropsychological impairment and disability in multiple sclerosis is challenging. We report methodologic details on a new test, the Multiple Sclerosis Performance Test (MSPT). This new approach to the objective of quantification of MS related disability provides a computer-based platform for precise, valid measurement of MS severity.
09:38
Quantitative Assessment of Cortical Auditory-tactile Processing in Children with Disabilities
0 Views •
Cited by 8 •
2014
Objective and easy measurement of sensory processing is extremely difficult in nonverbal or vulnerable pediatric patients. We developed a new methodology to quantitatively assess infants and children's cortical processing of light touch, speech sounds, and the multisensory processing of the 2 stimuli, without requiring active subject participation or causing discomfort in vulnerable patients.
08:11
Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis
0 Views •
Cited by 21 •
2016
An optimized testing protocol is presented in this paper for the Rotarod performance test, used for measuring progressive neurological disability in TMEV-infected mice.
01:29
Intellectual Disability
0 Views •
2025
Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...
01:25
Learning Disabilities
0 Views •
2025
Learning disabilities are cognitive disorders caused by neurological impairments that affect cognitive functions like language and reading, without indicating overall intellectual or developmental challenges. These disabilities differ from global intellectual or developmental disabilities as they are limited to distinct cognitive functions. Common learning disabilities include dysgraphia, dyslexia, and dyscalculia, each of which impacts unique aspects of learning. Dyslexia Dyslexia is a...
FAQs
The combined profile captures walking, manual dexterity, cognitive processing speed, and visual contrast sensitivity. Because multiple sclerosis can affect neurologic function in different ways, examining these domains can characterize disability more broadly than a single performance measure. This multidomain structure also gives clinicians and researchers several repeatable outcomes to review when evaluating change over time or response to treatment.
Standardized task instructions reduce variation in how assessments are presented and performed. When the same instructions and repeatable performance measures are used at different visits, results become easier to compare over time. This consistency supports longitudinal monitoring because differences in performance can be interpreted alongside possible disease-related change rather than being attributed simply to a different testing approach.
The assessment adds objective performance outcomes to information gathered during a conventional neurologic examination. Its tasks quantify functional performance across several neurologic domains, whereas the clinical examination provides a broader medical evaluation. Used together, these approaches can improve disability characterization and give clinicians an additional way to follow changes that may occur during disease progression or treatment.
Administration typically uses a tablet-based platform with standardized instructions for each task. The evaluation includes timed walking, manual dexterity, cognitive processing speed, and visual contrast sensitivity activities. This technology-supported format produces performance measures in a consistent manner, making the assessment practical for repeated use when clinicians or researchers need to compare functional outcomes across time.
Clinicians may use the assessment to characterize a person’s functional disability, monitor disease-related progression, or evaluate changes associated with treatment response. Because it samples walking, dexterity, cognition, and visual contrast, it can show performance across several relevant domains. The results complement conventional neurologic examinations and provide objective measures for longitudinal follow-up.
The assessment produces objective, repeatable outcomes that can support longitudinal and multisite research. Standardized task instructions and technology-supported administration help make performance measures more consistent when participants are evaluated repeatedly or at different study locations. Researchers can use these outcomes to examine disability changes over time, characterize functional effects, and assess patterns associated with treatment response.